News

ALF Inspires Runners at the 2025 Bank of America Marathon

ALF Inspires Runners at the 2025 Bank of America Marathon

ALF's Involvement in the Chicago Marathon

In a powerful testament to community spirit, the American Liver Foundation (ALF) has declared its role as a partner for the Chicago Marathon. This prestigious marathon, set in the heart of a bustling city, becomes a platform for ALF as runners gear up for the race, joining forces to raise awareness about liver disease. This initiative goes beyond just running; it’s about championing a cause that impacts countless lives.

Celebrating the Spirit of the Marathon

The Chicago marathon is not merely an endurance event. For ALF, it symbolizes hope and education surrounding liver health and disease prevention. It’s an opportunity for both seasoned and novice runners alike to come together with a shared mission, turning their strides into steps toward raising much-needed funds and awareness.

Team ALF's Dedication

ALF's team, comprising diverse runners from varying backgrounds, includes those with personal connections to liver diseases. Their collective efforts led to surpassing their fundraising goals, underscoring the commitment to supporting those affected by liver disease. The funds raised will be instrumental in enabling ALF to further its mission of patient care, education, and research.

Spotlight on Individual Stories

Among the committed participants is Greg Ciaciura, a dedicated individual who will be running his sixteenth marathon. As the Transplant Program Development Director at Northwestern Medicine, he brings a unique perspective on the impact of liver disease, being both a specialist and a compassionate advocate. Joining him is his son Dario, marking their shared journey as part of the ALF team.

Inspiring Narratives of Hope

Another inspiring team member is Sydney Flakus-Witte. As an employee at the Duchossois Family Institute, she understands the profound connection between research and patient outcomes. Her motivation to run this marathon is deeply personal, fueled by her partner’s battle with Primary Sclerosing Cholangitis.

Meet Other Team Members

ALF boasts a dedicated team of 38 runners. Among them is James Atkinson, participating as a tribute to his parents' liver transplant journeys. Megan Daniel runs in honor of her daughter, Addilyn, whose fight against Biliary Atresia reflects resilience at its finest. Each runner's story adds depth to the mission and amplifies the call for liver health awareness.

Fundraising Success and the Journey Forward

The enthusiasm doesn’t stop at raising funds; each participant shares a unique story that fosters community connection and drives awareness. From Alyson Doherty, who honors her aunt’s liver transplant journey, to Michael Doyen, who runs in tribute to his wife, the collective efforts during the marathon showcase courage and compassion.

Join ALF in Their Mission

As the marathon draws near, ALF invites everyone to support the runners and their noble tasks. Together, they aim to dismantle the stigma associated with liver diseases and bring hope to those in need. This community of advocacy and support demonstrates how running a marathon can also mean running for a cause.

Frequently Asked Questions

What is the American Liver Foundation?

The American Liver Foundation (ALF) is dedicated to the health of individuals affected by liver diseases, providing education, advocacy, and support.

How can I support the ALF marathon runners?

You can support the ALF team by donating to their fundraising efforts, which directly benefit liver disease research and patient support.

Who are some standout runners in the ALF team?

Notable runners include Greg Ciaciura and Sydney Flakus-Witte, who both share heartfelt stories tied to liver health advocacy.

What is the significance of running for ALF?

Running for ALF symbolizes awareness and unity in the fight against liver disease, encouraging education and community involvement.

How does the Chicago Marathon support liver disease awareness?

The marathon allows runners to spread awareness about liver health while raising essential funds for research and patient care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 266

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading